Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases

By          

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 689-692

Spandidos Publications

Access to resources Recommend Favorite

The cancertestis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo

By                        

Molecular Medicine Reports, Vol. 8, Iss. 5, 2013-01 ,pp. : 1549-1555

Spandidos Publications

Access to resources Recommend Favorite

Decitabine, a DNA methyltransferase inhibitor, induces apoptosis in human leukemia cells through intracellular reactive oxygen species generation

By Shin Dong Yeok   Park You-Soo   Yang Kwangmo   Kim Gi-Young   Kim Wun-Jae   Han Min Ho   Kang Ho Sung   Choi Yung Hyun  

International Journal of Oncology, Vol. 41, Iss. 3, 2012-09 ,pp. : 910-918

Spandidos Publications

Access to resources Recommend Favorite

Successful treatment with low-dose decitabine in acute myelogenous leukemia in elderly patients over 80 years old: Five case reports

By                

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1321-1324

Spandidos Publications

Access to resources Recommend Favorite

Epigenetic Regulation as a New Target for Breast Cancer Therapy

By Stearns Vered   Zhou Qun   Davidson Nancy  

Cancer Investigation, Vol. 25, Iss. 8, 2007-12 ,pp. : 659-665

Informa Healthcare

Access to resources Recommend Favorite